U.S. FDA warns GSK over problems at Quebec flu vaccine manufacturing plant
TORONTO - The company that makes much of Canada's annual flu vaccine has received a warning from the U.S. Food and Drug Administration.
GSK received a letter of warning from the FDA about conditions at its manufacturing facility at Ste-Foy, Que., where the company makes flu vaccine for the Canadian and U.S. markets.
The warning stems from an inspection of the plant conducted by FDA agents earlier this year.
The letter says the facility deviates from current good manufacturing practice requirements, the industry standards enforced by licensing agencies.
The letter raises concerns about the purified water system at the plant and other issues and gives the company 15 days in which to address the problems.
A statement from GSK says the company is making progress addressing the FDA's concerns and is committed to working with the regulatory agency to fully resolve all outstanding issues.
Read more Business News
- One injured in plane crashVernon / N. Okanagan - 11:40 am
- Parachutist hits houseVernon / N. Okanagan
- Boonstock liquor decision finalPenticton / S. Okanagan
- Sun shining on Copper SkyReal Estate - 11:38 am
|QHR Technologies Inc||1.19||+0.04|
|Anavex Life Sciences||0.26||-0.005|
|Copper Mountain Mining||2.89||-0.08|
|Sunrise Resources Ltd||0.025||+0.005|
|Mission Ready Services||0.17||-0.02|
Photo: Thinkstock.comWays to reduce your Debt:Make a budget and get budget counselingA basic first step for debt reduction is to prepare a budget and plan your spending. Once you have a budget, you mu...
The Big Picture Geopolitical tensions rattle markets The spectre of rising geopolitical tensions in Ukraine and Gaza cast a shadow over an otherwise positive week in the markets. News that a passenger...
Photo: ContributedI have the pleasure of witnessing people delegate tasks quite often. Sometimes with tremendous success and sometimes with disastrous consequences. I have chaired a lot of committees...